CIK 0000064803 · Large accelerated filer
CVS HEALTH Corp
Sign in to watch- Ticker
- CVS
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 050494040
- Phone
- 4017651500
- Business address
- ONE CVS DR., WOONSOCKET, RI, 02895
- Former names
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- Open-market buys, last 90 days
- $2,001,315
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,001,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-21 | Lotvin Alan EVP&President-PharmacyServices | Grant or award | +85,971 | 147,312.37 | ||
| 2022-02-21 | Finke Daniel P EVP/Pres, Health Care Benefits | Grant or award | +34,387 | 57,713.96 | ||
| 2022-02-21 | Clark James David SVP, Cont & Chief Acct Officer | Grant or award | +8,595 | 26,092.26 | ||
| 2022-02-21 | Brennan Troyen A EVP and Chief Medical Officer | Grant or award | +171,944 | 312,815.06 | ||
| 2022-02-10 | LUDWIG EDWARD J Director | Purchase | +1,000 | $105.90 | $106K | 18,334 |
| 2022-02-03 | Brennan Troyen A EVP and Chief Medical Officer | Option exercise | +47,937 | $102.26 | $4.9M | 186,183.06 |
| 2022-02-03 | Brennan Troyen A EVP and Chief Medical Officer | Sale | −47,937 | $110.00 | $5.3M | 138,246.06 |
| 2022-02-03 | Brennan Troyen A EVP and Chief Medical Officer | Option exercise · Stock Option | −47,937 | 0 | ||
| 2022-02-01 | Lotvin Alan EVP&President-PharmacyServices | Option exercise | +21,386 | $102.26 | $2.2M | 82,727.37 |
| 2022-02-01 | Lotvin Alan EVP&President-PharmacyServices | Sale | −21,386 | $106.50 | $2.3M | 61,341.37 |
| 2022-02-01 | Lotvin Alan EVP&President-PharmacyServices | Option exercise · Stock Option | −21,386 | 0 | ||
| 2022-01-28 | Clark James David SVP, Cont & Chief Acct Officer | Option exercise | +6,059 | $102.26 | $620K | 23,556.26 |
| 2022-01-28 | Clark James David SVP, Cont & Chief Acct Officer | Sale | −6,059 | $109.00 | $660K | 17,497.26 |
| 2022-01-28 | Clark James David SVP, Cont & Chief Acct Officer | Option exercise · Stock Option | −6,059 | 0 | ||
| 2022-01-27 | Roberts Jonathan C EVP & Chief Operating Officer | Option exercise | +68,482 | $102.26 | $7.0M | 175,596.72 |
| 2022-01-27 | Roberts Jonathan C EVP & Chief Operating Officer | Sale | −68,482 | $107.50 | $7.4M | 107,114.72 |
| 2022-01-27 | Roberts Jonathan C EVP & Chief Operating Officer | Option exercise · Stock Option | −68,482 | 0 | ||
| 2021-12-27 | Lotvin Alan EVP&President-PharmacyServices | Shares withheld for taxes | −200 | $88.78 | $18K | 5,827 |
| 2021-12-01 | Clark James David SVP, Cont & Chief Acct Officer | Shares withheld for taxes | −266 | $88.78 | $24K | 16,723 |
| 2021-12-01 | Clark James David SVP, Cont & Chief Acct Officer | Shares withheld for taxes | −68 | $88.78 | $6K | 16,921 |
Page 21 of 24 · 466 trades